HER2 Testing Market Players:
- Agilent Technologies, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Thermo Fisher Scientific
- Roche
- Empire Genomics Inc.
- Abnova Corporation
- Eli Lilly and Company
- Oxford Gene Technology IP Limited
- Genetech
- Genemed Technologies Inc.
- PERKINELMER Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of HER2 testing is evaluated at USD 177.12 million.
The global HER2 testing market size was worth over USD 166.34 million in 2025 and is poised to grow at a CAGR of around 7.2%, reaching USD 333.38 million revenue by 2035.
North America is expected to capture a 44% share of the HER2 testing market by 2035, supported by its strong product adoption and substantial need for HER2 diagnostics owing to rising breast cancer incidence.
Key players in the market include Thermo Fisher Scientific, Roche, Empire Genomics Inc., Abnova Corporation, Eli Lilly and Company, Oxford Gene Technology IP Limited, Genetech, Genemed Technologies Inc., PERKINELMER Inc.
